Maryse Belleville

Title: Maryse Belleville: Innovator in Pharmaceutical Sciences

Introduction

Maryse Belleville is a notable inventor based in Lyon, France. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of innovative medicinal formulations. With a total of 2 patents, her work focuses on improving treatment options for various medical conditions.

Latest Patents

Maryse Belleville's latest patents include groundbreaking formulations aimed at enhancing therapeutic efficacy. One of her notable inventions is a long-acting theophylline in medicinal form, which is designed for treating asthma. This formulation comprises theophylline associated with a compound of the substituted cinnamamide type, providing a novel approach to asthma management. Another significant patent is for prolonged-release pharmaceutical compositions for oral administration. This composition includes a dosage of the acid oralate of naftidrofuryl, featuring a prolonged release coating that ensures sustained therapeutic activity for treating arterial diseases and circulatory disorders.

Career Highlights

Maryse Belleville is currently associated with Lipha, a prominent pharmaceutical company in Lyon, known for its innovative healthcare solutions. Her work at Lipha has allowed her to focus on developing advanced pharmaceutical formulations that address critical health issues.

Collaborations

Throughout her career, Maryse has collaborated with esteemed colleagues, including Francoise Merle and Jean-Claude Lechevin. These partnerships have fostered a collaborative environment that enhances the innovation process in pharmaceutical research.

Conclusion

Maryse Belleville's contributions to pharmaceutical sciences exemplify her commitment to improving patient care through innovative medicinal formulations. Her patents reflect a dedication to addressing complex health challenges, making her a significant figure in the field.